These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16384814)

  • 21. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A
    Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
    [No Abstract]   [Full Text] [Related]  

  • 22. MDMA (Ecstasy) use and psychiatric problems.
    Guillot CR; Berman ME
    Psychopharmacology (Berl); 2007 Jan; 189(4):575-6. PubMed ID: 17061108
    [No Abstract]   [Full Text] [Related]  

  • 23. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific memory deficits in ecstasy users? The results of a meta-analysis.
    Verbaten MN
    Hum Psychopharmacol; 2003 Jun; 18(4):281-90. PubMed ID: 12766933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling the adverse effects associated with ecstasy use.
    Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F
    Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
    Zakzanis KK; Campbell Z; Jovanovski D
    Hum Psychopharmacol; 2007 Oct; 22(7):427-35. PubMed ID: 17896346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
    Downey LA; Sands H; Jones L; Clow A; Evans P; Stalder T; Parrott AC
    Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New Drugs: Ectasy and Gamma-Hydroxy-Butyrate (GHB)].
    Feldman N; Croquette-Krokar M
    Vertex; 2002; 13(47):5-8. PubMed ID: 11967570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Everyday and prospective memory deficits in ecstasy/polydrug users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    J Psychopharmacol; 2011 Apr; 25(4):453-64. PubMed ID: 20123936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis, ecstasy/MDMA and memory: a commentary on Simon & Mattick's recent study.
    Parrott AC; Fox H; Milani RM
    Addiction; 2003 Jul; 98(7):1003-4; author reply 1004-5. PubMed ID: 12814506
    [No Abstract]   [Full Text] [Related]  

  • 31. Criminal involvement among young male ecstasy users.
    Hendrickson JC; Gerstein DR
    Subst Use Misuse; 2005; 40(9-10):1557-75. PubMed ID: 16048833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug Design].
    Abanades S; Farré M
    Med Clin (Barc); 2003 Jun; 121(1):38. PubMed ID: 12812711
    [No Abstract]   [Full Text] [Related]  

  • 33. Long term psychiatric and cognitive effects of MDMA use.
    McGuire P
    Toxicol Lett; 2000 Mar; 112-113():153-6. PubMed ID: 10720725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of 'ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses.
    Murphy PN; Bruno R; Ryland I; Wareing M; Fisk JE; Montgomery C; Hilton J
    Hum Psychopharmacol; 2012 Mar; 27(2):113-38. PubMed ID: 22389076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Abuse of Ecstasy (3,4-methylenedioxymethamphetamine). Pharmacological, neuropsychiatric and behavioral aspects].
    Nielsen JC; Nicholson K; Pitzner-Jørgensen BL; Undén M
    Ugeskr Laeger; 1995 Feb; 157(6):724-7. PubMed ID: 7701630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal and visual source memory deficits among ecstasy/polydrug users.
    Fisk JE; Gallagher DT; Hadjiefthyvoulou F; Montgomery C
    Hum Psychopharmacol; 2014 Mar; 29(2):172-82. PubMed ID: 24446108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12):574-6. PubMed ID: 10683753
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ecstasy is a dangerous drug the society chooses to ignore].
    Heilig M
    Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
    [No Abstract]   [Full Text] [Related]  

  • 39. From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.
    McCaughan JA; Carlson RG; Falck RS; Siegal HA
    Subst Use Misuse; 2005; 40(9-10):1503-23. PubMed ID: 16048830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.